SRS Capital Advisors Inc. Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SRS Capital Advisors Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,208 shares of the medical equipment provider’s stock after buying an additional 432 shares during the quarter. SRS Capital Advisors Inc.’s holdings in Intuitive Surgical were worth $1,674,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $360,000. Clifford Swan Investment Counsel LLC boosted its position in Intuitive Surgical by 13.0% during the 4th quarter. Clifford Swan Investment Counsel LLC now owns 1,187 shares of the medical equipment provider’s stock valued at $620,000 after acquiring an additional 137 shares in the last quarter. Norden Group LLC increased its holdings in shares of Intuitive Surgical by 8.9% in the 4th quarter. Norden Group LLC now owns 1,746 shares of the medical equipment provider’s stock valued at $911,000 after acquiring an additional 142 shares during the period. Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth $31,000. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Intuitive Surgical by 20.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 4,032 shares of the medical equipment provider’s stock worth $2,125,000 after purchasing an additional 673 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.7 %

Shares of ISRG stock opened at $573.15 on Friday. The company has a market cap of $204.14 billion, a P/E ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39. The firm has a fifty day moving average price of $569.87 and a 200 day moving average price of $529.06. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,077 shares of company stock valued at $4,620,025. 0.90% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have issued reports on ISRG. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, BTIG Research increased their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.